PubMed HealthSearch

PubMed · 6561255

A new inductive applicator for hyperthermia.

Abstract

We have designed a new type of applicator for inductive heating which consists of a one-turn, square, column-like coil, through which RF current flows. The material to be heated is placed alongside one of the external sides of the coil. The depth of penetration from an applicator with a height of 20 cm, width of 20 cm, depth of 60 cm was calculated to be 11.7 cm. However, in experiments using a muscle-equivalent agar phantom 60 cm X 60 cm X 60 cm, the penetration depth proved to be 9.6 cm; but in another experiment using a smaller phantom 20 cm X 40 cm X 60 cm, the penetration depth was 6.3 cm. This means that the depth of penetration depends not only on the size of the applicator but also on the shape of the material heated. Our study clearly showed that this applicator produces much less heat in the fat layer than in the muscle layer and should be an inductive applicator suitable for deep heating cancer therapy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Kato, T Ishida. 1983. A new inductive applicator for hyperthermia.. https://doi.org/10.1080/16070658.1983.11689339

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Design of a microwave array hyperthermia applicator with a semicircular reflector.

The design of a hyperthermia applicator for heating biological tissues is presented in which the applicator consists of an array antenna surrounded by a perfect electrically conducting reflector. The heat hazard to superficial tissues is reduced by the introduction of a dielectric protecting layer over them. A method of moments formulation is applied to approximate the electric field within the biological medium and a closed form expression is presented for the electromagnetic coupling problem, which enables an optimisation procedure to be performed. The applicator enhances both penetration and focusing: deep tumours, close to the bone region, are heated and the percentage of biologically healthy tissue exposed to a specific absorption rate (SAR) hazard level diminishes by 53.8%.

Diathermy

Transurethral microwave thermotherapy.

OBJECTIVES AND METHODS: The present status of transurethral microwave thermotherapy (TUMT) in the low (LE) and high energy (HE) version is given as an overview. RESULTS: With LE software, approximately 75% of patients will note significant improvement with 65% reduction in symptom scores and a 35-40% improvement in peak flow rate. Sham studies have shown statistically significant improvement in treated patients compared to sham. Randomized studies between TUMT and TURP show similar improvements in symptom scores with TURP producing higher flow rates, as expected. Long-term studies have been reported to 5 years showing durability, although 10-20% of patients subsequently undergo TURP. The clinical efficacy of HE-TUMT 2.5 has been documented in recently completed studies. Approximately 37% of patients develop cavitation with HE-TUMT. The symptomatic improvement is similar between low and high energy while the flow rates with high energy improve by approximately 65%. Pressure flow studies have documented relief of obstruction in most of those patients who had obstruction prior to treatment. The morbidity of HE-TUMT in terms of retrograde ejaculation and posttreatment retention is higher compared to the LE version. CONCLUSIONS: TUMT is a 1-hour out-patient, local anesthetic procedure, minimally invasive treatment option for benign prostatic hyperplasia that encompasses microwave radiative heating and water conductive cooling. TUMT has been proven both safe and efficacious for relieving benign prostatic hyperplasia symptoms in several large-scale controlled studies. The existence of low and high energy versions offers the opportunity to select patients according to obstruction grade.

Diathermy